MiR-30b regulates migration and invasion of human colorectal cancer via SIX1

Biochemical Journal

Volumn 460, Issue 1, 2014, Pages 117-125

  Zhao, Hui ^a   Xu, Zifeng ^a   Qin, Huanlong ^a   Gao, Zhuo ^b,c   Gao, Lu ^c,d  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Center of Metabolic Disease Research Nanjing Medical University ^*  (China)

Author keywords

Colorectal cancer (crc); Invasion; Migration; Mir 30b; Six homeobox 1 (six1)

Indexed keywords

MICRORNA; MICRORNA 30B; TRANSCRIPTION FACTOR SIX1; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84899436615     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20131535     Document Type: Article

References (44)

1. Rodriguez-Cuellar, E., Ruiz Lopez, P., Romero Simo, M., Landa Garcia, J. I., Roig Vila, J. V. and Ortiz Hurtado, H. (2010) Analysis of the quality of surgical treatment of colorectal cancer, in 2008. A national study. Cir. Esp. 88, 238-246 CrossRef
2. Grothey, A. (2012) Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting. Clin. Adv. Hematol. Oncol. 10, 1-24 PubMed
3. Pulitano, C., Castillo, F., Aldrighetti, L., Bodingbauer, M., Parks, R. W., Ferla, G., Wigmore, S. J. and Garden, O. J. (2010) What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB 12, 244-249 PubMed
4. Chua, T. C. and Morris, D. L. (2012) Resectable colorectal liver metastases: optimal sequencing of chemotherapy. J. Gastrointest. Cancer. 43, 496-498 CrossRef PubMed
5. Tomlinson, J. S., Jarnagin, W. R., DeMatteo, R. P., Fong, Y., Kornprat, P., Gonen, M., Kemeny, N., Brennan, M. F., Blumgart, L. H. and D'Angelica, M. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol. 25, 4575-4580 CrossRef PubMed
6. Zdenkowski, N., Chen, S., van der Westhuizen, A. and Ackland, S. (2012) Curative strategies for liver metastases from colorectal cancer: a review. Oncologist 17, 201-211 CrossRef PubMed
7. de Jong, G. M., Aarts, F., Hendriks, T., Boerman, O. C. and Bleichrodt, R. P. (2009) Animal models for liver metastases of colorectal cancer: research review of preclinical studies in rodents. J. Surg. Res. 154, 167-176 CrossRef PubMed
8. Bird, N. C., Mangnall, D. and Majeed, A. W. (2006) Biology of colorectal liver metastases: a review. J. Surg. Oncol. 94, 68-80 CrossRef PubMed
9. Zeng, Z. S., Shu, W. P., Cohen, A. M. and Guillem, J. G. (2002) Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin. Cancer Res. 8, 144-148 PubMed
10. Sutnar, A., Pesta, M., Liska, V., Treska, V., Skalicky, T., Kormunda, S., Topolcan, O., Cerny, R. and Holubec, Jr, L. (2007) Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases. Tumour Biol. 28, 247-252 CrossRef PubMed
11. Gorden, D. L., Fingleton, B., Crawford, H. C., Jansen, D. E., Lepage, M. and Matrisian, L. M. (2007) Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. Int. J. Cancer. 121, 495-500 CrossRef PubMed
12. Makino, M., Yamane, N., Taniguchi, T., Honboh, T., Kurayoshi, K. and Kaibara, N. (2000) p53 as an indicator of lymph node metastases in invasive early colorectal cancer. Anticancer Res. 20, 2055-2059 PubMed
13. de Jong, K. P., Gouw, A. S., Peeters, P. M., Bulthuis, M., Menkema, L., Porte, R. J., Slooff, M. J., van Goor, H. and van den Berg, A. (2005) P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. Clin. Cancer Res. 11, 4067-4073 CrossRef PubMed
14. Kovar, F. M., Thallinger, C., Marsik, C. L., Perkmann, T., Puhalla, H., Haslacher, H., Wrba, F., Wagner, O. F., Gruenberger, T. and Endler, G. (2009) The EGF 61A/G polymorphism: a predictive marker for recurrence of liver metastases from colorectal cancer. Wien. Klin. Wochenschr. 121, 638-643 CrossRef PubMed
15. Gunasinghe, N. P., Wells, A., Thompson, E. W. and Hugo, H. J. (2012) Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev. 31, 469-478 CrossRef PubMed
16. Yao, D., Dai, C. and Peng, S. (2011) Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol. Cancer Res. 9, 1608-1620 CrossRef PubMed
17. Talbot, L. J., Bhattacharya, S. D. and Kuo, P. C. (2012) Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int. J. Biochem. Mol. Biol. 3, 117-136 PubMed
18. Bates, R. C. and Mercurio, A. M. (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4, 365-370 CrossRef PubMed
19. Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T. and Brabletz, T. (2006) A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131, 830-840 CrossRef PubMed
20. Takahashi, Y., Sawada, G., Kurashige, J., Uchi, R., Matsumura, T., Ueo, H., Takano, Y., Akiyoshi, S., Eguchi, H., Sudo, T. et al. (2013) Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer. Br. J. Cancer 109, 307-311 CrossRef PubMed
21. Ono, H., Imoto, I., Kozaki, K., Tsuda, H., Matsui, T., Kurasawa, Y., Muramatsu, T., Sugihara, K. and Inazawa, J. (2012) SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 31, 4923-4934 CrossRef PubMed
22. McCarthy, N. (2012) Metastasis: SIX1 of the best. Nat. Rev. Cancer 12, 316 CrossRef PubMed
23. Liu, X., Fortin, K. and Mourelatos, Z. (2008) MicroRNAs: biogenesis and molecular functions. Brain Pathol. 18, 113-121 CrossRef PubMed
24. Quintavalle, C., Donnarumma, E., Iaboni, M., Roscigno, G., Garofalo, M., Romano, G., Fiore, D., De Marinis, P., Croce, C. M. and Condorelli, G. (2012) Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene 32, 4001-4008 CrossRef PubMed
25. Zhu, H., Wu, H., Liu, X., Li, B., Chen, Y., Ren, X., Liu, C. G. and Yang, J. M. (2009) Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a , in cancer cells. Autophagy 5, 816-823 PubMed
26. Yang, X., Zhong, X., Tanyi, J. L., Shen, J., Xu, C., Gao, P., Zheng, T. M., Demichele, A. M. and Zhang, L. (2012) mir-30d regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells. Biochem. Biophys. Res. Commun. 431, 617-722 CrossRef PubMed
27. Ozcan, S. (2009) MiR-30 family and EMT in human fetal pancreatic islets. Islets 1, 283-285 CrossRef PubMed
28. Joglekar, M. V., Patil, D., Joglekar, V. M., Rao, G. V., Reddy, D. N., Mitnala, S., Shouche, Y. and Hardikar, A. A. (2009) The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 1, 137-147 CrossRef PubMed
29. Ng, K. T., Lee, T. K., Cheng, Q., Wo, J. Y., Sun, C. K., Guo, D. Y., Lim, Z. X., Lo, C. M., Poon, R. T., Fan, S. T. and Man, K. (2010) Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. Int. J. Cancer 127, 859-872 PubMed
30. Wang, C. A., Jedlicka, P., Patrick, A. N., Micalizzi, D. S., Lemmer, K. C., Deitsch, E., Casas-Selves, M., Harrell, J. C. and Ford, H. L. (2012) SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J. Clin. Invest. 122, 1895-1906 CrossRef PubMed
31. Micalizzi, D. S., Christensen, K. L., Jedlicka, P., Coletta, R. D., Baron, A. E., Harrell, J. C., Horwitz, K. B., Billheimer, D., Heichman, K. A., Welm, A. L. et al. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling. J. Clin. Invest. 119, 2678-2690 CrossRef PubMed
32. Petrelli, N. (2006) Surgical management of liver metastases from colorectal cancer. Clin. Adv. Hematol. Oncol. 4, 673-675 PubMed
33. Kemeny, N. (2006) Management of liver metastases from colorectal cancer. Oncology 20, 1161-1176 PubMed
34. Qamar, L., Deitsch, E., Patrick, A. N., Post, M. D., Spillman, M. A., Iwanaga, R., Thorburn, A., Ford, H. L. and Behbakht, K. (2012) Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer. Gynecol. Oncol. 125, 451-457 CrossRef PubMed
35. Tan, J., Zhang, C. and Qian, J. (2011) Expression and significance of Six1 and Ezrin in cervical cancer tissue. Tumour Biol. 32, 1241-1247 CrossRef PubMed
36. Reichenberger, K. J., Coletta, R. D., Schulte, A. P., Varella-Garcia, M. and Ford, H. L. (2005) Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res. 65, 2668-2675 CrossRef PubMed
37. McCoy, E. L., Iwanaga, R., Jedlicka, P., Abbey, N. S., Chodosh, L. A., Heichman, K. A., Welm, A. L. and Ford, H. L. (2009) Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J. Clin. Invest. 119, 2663-2677 CrossRef PubMed
38. McCoy, E. L., Kawakami, K., Ford, H. L. and Coletta, R. D. (2009) Expression of Six1 homeobox gene during development of the mouse submandibular salivary gland. Oral. Dis. 15, 407-413 CrossRef PubMed
39. Kao, C. J., Martiniez, A., Shi, X. B., Yang, J., Evans, C. P., Dobi, A., Devere White, R. W. and Kung, H. J. (2013) miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene, doi:10.1038/onc.2013.200
40. Zhong, M., Bian, Z. and Wu, Z. (2013) miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell. Physiol. Biochem. 31, 209-218 CrossRef PubMed
41. Ouzounova, M., Vuong, T., Ancey, P. B., Ferrand, M., Durand, G., Le-Calvez Kelm, F., Croce, C., Matar, C., Herceg, Z. and Hernandez-Vargas, H. (2013) MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics 14, 139 CrossRef PubMed
42. Xia, Y., Chen, Q., Zhong, Z., Xu, C., Wu, C., Liu, B. and Chen, Y. (2013) Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1. Cell. Physiol. Biochem. 32, 476-485 CrossRef PubMed
43. Huang, J., Yao, X., Zhang, J., Dong, B., Chen, Q., Xue, W., Liu, D. and Huang, Y. (2013) Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma. Cancer Sci. 104, 1609-1617 CrossRef PubMed
44. Hur, K., Toiyama, Y., Takahashi, M., Balaguer, F., Nagasaka, T., Koike, J., Hemmi, H., Koi, M., Boland, C. R. and Goel, A. (2012) MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 62, 1315-1326 CrossRef PubMed